This finding suggests that in the early stages of AD, the genetic control of the rate of cognitive decline is mainly unrelated to APOE, once taking Aβ burden into account (although the age of onset of AD is clearly affected by APOE genotype32). The gene discussed is APOE; the disease is Alzheimer disease.